Drug companies are struggling to develop new and more effective
antibiotics to combat the growing worldwide threat from drug-resistant
germs. In this second of her 2-part report on "Battling Superbugs,"
VOA examines the looming public health danger, and the challenges drug
companies face in bringing new antibiotics to market.
Medical experts watching the rising tide of drug-resistant bacteria
have begun sounding the alarms. They say life-threatening infections
could jeopardize surgeries, cancer treatment, organ transplants, and
many other specialized medical procedures.